Physician profile
Michael S Beecher
NPI 1689672891
$1,476.20
in general payments reported to CMS, 2019-2025
11 companies · $262 in 2025
The $262 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $37.62 · 2021: $178 · 2022: $191 · 2023: $135 · 2024: $543 · 2025: $262.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $484.62 | 2024-2025 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $322.36 | 2022-2024 | Optimizer |
| Penumbra, INC. | $203.37 | 2021-2022 | |
| Boston Scientific Corporation | $135.28 | 2023 | Watchman Access System |
| Allergan, INC. | $77.47 | 2019-2020 | |
| Inari Medical, INC. | $73.77 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $65.09 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.59 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $21.90 | 2022 | |
| W. L. Gore & Associates, INC. | $18.19 | 2025 | Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Abbvie INC. | $14.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Beecher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.